Similar articles

• Rate of inactivation of adenyl cyclase and phosphodiesterase: determinants of brain cyclic AMP.

  Jones DJ, Medina MA, Ross DH, Stavinoha WB. Jones DJ, et al. Life Sci. 1974 Apr 16;14(8):1577-85. doi: 10.1016/0024-3205(74)90168-4. Life Sci. 1974. PMID: 4364281 No abstract available.
• Neuronal localization of the enhanced adenylate cyclase responsiveness to catecholamines in the rat cerebral cortex following reserpine injections.

  Palmer GC, Wagner HR, Putnam RW. Palmer GC, et al. Neuropharmacology. 1976 Nov;15(11):695-702. doi: 10.1016/0028-3908(76)90039-3. Neuropharmacology. 1976. PMID: 187979 No abstract available.
• Changes in activity and hormonal sensitivity of brain adenyl cyclase following chronic ethanol administration.

  Israel MA, Kimura H, Kuriyama K. Israel MA, et al. Experientia. 1972 Nov 15;28(11):1322-3. doi: 10.1007/BF01965322. Experientia. 1972. PMID: 4344703 No abstract available.
• On the development and properties of the brain adenyl cyclase system.

  Robison GA, Schmidt MJ, Sutherland EW. Robison GA, et al. Adv Biochem Psychopharmacol. 1970;3:11-30. Adv Biochem Psychopharmacol. 1970. PMID: 4331453 Review. No abstract available.
• Reserpine-induced supersensitivity to the cardiac effects of agonists.

  Meisheri KD, Tenner TE Jr, McNeill JH. Meisheri KD, et al. Life Sci. 1979 Feb 5;24(6):473-80. doi: 10.1016/0024-3205(79)90167-x. Life Sci. 1979. PMID: 219312 Review. No abstract available.